ログイン
Language:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 原著論文

Efficacy of Radiotherapy for Oligometastatic Lung Cancer and Irradiation Methods Based on Metastatic Site.

https://repo.qst.go.jp/records/2001861
https://repo.qst.go.jp/records/2001861
89a509c0-1f06-4fe3-bae3-0d98cd053a91
アイテムタイプ 学術雑誌論文 / Journal Article(1)
公開日 2025-08-26
タイトル
タイトル Efficacy of Radiotherapy for Oligometastatic Lung Cancer and Irradiation Methods Based on Metastatic Site.
言語 en
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
著者 Katsuyuki Shirai

× Katsuyuki Shirai

Katsuyuki Shirai

Search repository
Masashi Endo

× Masashi Endo

Masashi Endo

Search repository
Shuri Aoki

× Shuri Aoki

Shuri Aoki

Search repository
Noriko Kishi

× Noriko Kishi

Noriko Kishi

Search repository
Yukiko Fukuda

× Yukiko Fukuda

Yukiko Fukuda

Search repository
Tetsuo Nonaka

× Tetsuo Nonaka

Tetsuo Nonaka

Search repository
Hitoshi Ishikawa

× Hitoshi Ishikawa

Hitoshi Ishikawa

Search repository
抄録
内容記述タイプ Abstract
内容記述 Systemic chemotherapy is a standard treatment for patients with stage IV cancer with distant metastases, and there is little evidence of the effectiveness of local treatments for distant metastatic lesions. However, in recent years, randomized phase II trials targeting oligometastases in lung cancer and solid tumors have reported that local therapy combined with systemic chemotherapy improves clinical outcomes. We reviewed previous clinical trials and demonstrated the efficacy of radiotherapy for oligometastatic disease. Stereotactic body radiotherapy (SBRT) is a promising treatment that achieves high local control rates for oligometastatic disease. Although SBRT generally does not cause severe adverse events, the safety of SBRT combined with systemic chemotherapy needs to be carefully considered. We discussed the efficacy and safety of SBRT and summarized the details of SBRT methods and techniques for each metastatic site. Further research and clinical trials are warranted to improve the efficacy of SBRT combined with systemic chemotherapy for oligometastatic non-small cell lung cancer (NSCLC).
書誌情報 Cancers

巻 17, 号 15, 発行日 2025-08
ISSN
収録物識別子タイプ ISSN
収録物識別子 2072-6694
PubMed番号
識別子タイプ PMID
関連識別子 40805265
DOI
識別子タイプ DOI
関連識別子 10.3390/cancers17152569
戻る
0
views
See details
Views

Versions

Ver.1 2026-01-06 05:25:27.865644
Show All versions

Share

Share
tweet

Cite as

Other

print

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX
  • ZIP

コミュニティ

確認

確認

確認


Powered by WEKO3


Powered by WEKO3